People who did not want injections now have a pill option that has been shown to work in studies
The reported daily fluid intake decreased for patients on dulaglutide from a median (IQR) of 4500 [3625, 5000] mL to 3000 [2500, 3875] mL, while it remained constant with placebo treatment, from 4000 [4000, 5000] mL to 4000 [3500, 5000] mL
Patients treated with dietary supplements containing alpha-lipoic acid, acetyl-L-carnitine, and a vitamin B complex (Tioneural retard), which act synergistically on inflammation of the peripheral nervous system, showed a reduction in the VAS score attributed to neuralgic discomfort
This is a near-maximum dose that produces more pronounced GI symptoms
however, several major insurers recognize semaglutide as a necessary treatment for weight management